Barbara Ann Karmanos Cancer Institute - Karmanos Cancer Center - Main Campus — Detroit, Michigan

Barbara Ann Karmanos Cancer Institute - Karmanos Cancer Center - Main Campus is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Barbara Ann Karmanos Cancer Institute - Karmanos Cancer Center - Main Campus has participated in 2 clinical trials.

Therapeutic areas: Relapsed/Refractory Multiple Myeloma, Carcinoma, Hepatocellular.

Sponsors: Ichnos Sciences SA, Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Barbara Ann Karmanos Cancer Institute - Karmanos Cancer Center - Main Campus?

Barbara Ann Karmanos Cancer Institute - Karmanos Cancer Center - Main Campus has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Barbara Ann Karmanos Cancer Institute - Karmanos Cancer Center - Main Campus conducted?

Barbara Ann Karmanos Cancer Institute - Karmanos Cancer Center - Main Campus has 2 clinical trials on record. Their work covers Relapsed/Refractory Multiple Myeloma, Carcinoma, Hepatocellular.

Is Barbara Ann Karmanos Cancer Institute - Karmanos Cancer Center - Main Campus accredited by Crixeo Health?

Barbara Ann Karmanos Cancer Institute - Karmanos Cancer Center - Main Campus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Barbara Ann Karmanos Cancer Institute - Karmanos Cancer Center - Main Campus?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.